Description
Lee's Pharmaceutical Holdings Ltd is a Cayman Island-based research-driven and market-oriented biopharmaceutical company. It is integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales, and marketing in China with global perspectives. It focuses on cardiovascular, woman's health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. Its portfolio has two categories of Proprietary products and Licensed-in products. Its maximum revenue is generated from China. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Eyprotor. Its Licensed-in Products include Carnitene, Ferplex, ALOXI, and Centraxal Plus, among others.